دورية أكاديمية
أعرض في EDS

Oxonium ion scanning mass spectrometry for large-scale plasma glycoproteomics.

التفاصيل البيبلوغرافية
العنوان: Oxonium ion scanning mass spectrometry for large-scale plasma glycoproteomics.
المؤلفون: White MEH; Molecular Biology of Metabolism Laboratory, The Francis Crick Institute, London, UK., Sinn LR; Department of Biochemistry, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Jones DM; Bioinformatics and Computational Biology Laboratory, The Francis Crick Institute, London, UK.; Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, London, UK., de Folter J; Software Engineering and Artificial Intelligence Technology Platform, The Francis Crick Institute, London, UK., Aulakh SK; Molecular Biology of Metabolism Laboratory, The Francis Crick Institute, London, UK., Wang Z; Department of Biochemistry, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Flynn HR; Mass Spectrometry Proteomics Science Technology Platform, The Francis Crick Institute, London, UK., Krüger L; Institute of Diagnostic Laboratory Medicine, Charité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Human Medicine, Medical School Berlin, Berlin, Germany., Tober-Lau P; Department of Infectious Diseases and Critical Care Medicine, Charité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Demichev V; Molecular Biology of Metabolism Laboratory, The Francis Crick Institute, London, UK.; Department of Biochemistry, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Kurth F; Department of Infectious Diseases and Critical Care Medicine, Charité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Mülleder M; Core Facility High-throughput Mass Spectrometry, Charité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Blanchard V; Institute of Diagnostic Laboratory Medicine, Charité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Human Medicine, Medical School Berlin, Berlin, Germany., Messner CB; Molecular Biology of Metabolism Laboratory, The Francis Crick Institute, London, UK. christoph.messner@siaf.uzh.ch.; Precision Proteomic Center, Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland. christoph.messner@siaf.uzh.ch., Ralser M; Molecular Biology of Metabolism Laboratory, The Francis Crick Institute, London, UK. markus.ralser@charite.de.; Department of Biochemistry, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. markus.ralser@charite.de.; Max Planck Institute for Molecular Genetics, Berlin, Germany. markus.ralser@charite.de.
المصدر: Nature biomedical engineering [Nat Biomed Eng] 2024 Mar; Vol. 8 (3), pp. 233-247. Date of Electronic Publication: 2023 Jul 20.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Springer Nature Country of Publication: England NLM ID: 101696896 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2157-846X (Electronic) Linking ISSN: 2157846X NLM ISO Abbreviation: Nat Biomed Eng Subsets: MEDLINE
أسماء مطبوعة: Publication: London : Springer Nature
Original Publication: [London] : Macmillan Publishers Limited, [2016]-
مواضيع طبية MeSH: Glycopeptides*/analysis , Glycopeptides*/chemistry , Glycopeptides*/metabolism , COVID-19*, Humans ; Mass Spectrometry ; Glycosylation ; Ions
مستخلص: Protein glycosylation, a complex and heterogeneous post-translational modification that is frequently dysregulated in disease, has been difficult to analyse at scale. Here we report a data-independent acquisition technique for the large-scale mass-spectrometric quantification of glycopeptides in plasma samples. The technique, which we named 'OxoScan-MS', identifies oxonium ions as glycopeptide fragments and exploits a sliding-quadrupole dimension to generate comprehensive and untargeted oxonium ion maps of precursor masses assigned to fragment ions from non-enriched plasma samples. By applying OxoScan-MS to quantify 1,002 glycopeptide features in the plasma glycoproteomes from patients with COVID-19 and healthy controls, we found that severe COVID-19 induces differential glycosylation in IgA, haptoglobin, transferrin and other disease-relevant plasma glycoproteins. OxoScan-MS may allow for the quantitative mapping of glycoproteomes at the scale of hundreds to thousands of samples.
(© 2023. The Author(s).)
References: J Adv Res. 2023 Sep 6;:. (PMID: 37683725)
Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):11848-53. (PMID: 21712440)
Anal Chem. 2020 Mar 17;92(6):4518-4526. (PMID: 32091889)
Nat Med. 2022 Jun;28(6):1277-1287. (PMID: 35654907)
J Neurosci Res. 2021 May;99(5):1308-1324. (PMID: 33634546)
Cell Syst. 2020 Jul 22;11(1):11-24.e4. (PMID: 32619549)
J Proteome Res. 2016 Oct 7;15(10):3904-3915. (PMID: 27519006)
Mol Cell Proteomics. 2014 Aug;13(8):1914-24. (PMID: 24895383)
Anal Chem. 2021 Oct 19;93(41):13774-13782. (PMID: 34622651)
Mol Cell Proteomics. 2020 Apr;19(4):672-689. (PMID: 32102970)
Angew Chem Int Ed Engl. 2018 Jul 20;57(30):9320-9324. (PMID: 29742324)
J Mass Spectrom. 2013 Jun;48(6):627-39. (PMID: 23722953)
Mol Cell Proteomics. 2002 Nov;1(11):845-67. (PMID: 12488461)
PLoS One. 2014 Apr 22;9(4):e95192. (PMID: 24755770)
Breast Cancer Res Treat. 2019 Aug;176(3):545-556. (PMID: 31054033)
Nat Rev Drug Discov. 2021 Mar;20(3):217-243. (PMID: 33462432)
J Proteome Res. 2017 Feb 3;16(2):1069-1076. (PMID: 27978624)
Mol Cell Proteomics. 2016 Jul;15(7):2435-47. (PMID: 27094473)
Nat Commun. 2020 Feb 7;11(1):787. (PMID: 32034161)
Anal Bioanal Chem. 2017 Jan;409(2):619-627. (PMID: 27822650)
Rapid Commun Mass Spectrom. 2018 Jan 30;32(2):75-85. (PMID: 29055059)
Nat Biomed Eng. 2024 Mar;8(3):233-247. (PMID: 37474612)
Bioanalysis. 2017 Dec;9(23):1839-1844. (PMID: 29171768)
Nat Med. 2019 Dec;25(12):1843-1850. (PMID: 31806903)
Mol Syst Biol. 2017 Sep 26;13(9):942. (PMID: 28951502)
Infection. 2020 Aug;48(4):619-626. (PMID: 32535877)
Mol Cell Proteomics. 2005 Feb;4(2):144-55. (PMID: 15608340)
Front Immunol. 2021 Jan 14;11:608466. (PMID: 33519818)
Nat Biotechnol. 2021 Jul;39(7):846-854. (PMID: 33767396)
Glycoconj J. 2021 Feb;38(1):1-11. (PMID: 33547992)
Annu Rev Pathol. 2015;10:473-510. (PMID: 25621663)
J Proteome Res. 2014 Dec 5;13(12):6024-32. (PMID: 25358049)
Mol Omics. 2020 Apr 1;16(2):100-112. (PMID: 32104808)
Mol Cell Proteomics. 2021;20:100081. (PMID: 33862227)
Mol Cell Proteomics. 2014 Jul;13(7):1753-68. (PMID: 24741114)
Chemistry. 2016 Jan 18;22(3):1114-24. (PMID: 26663535)
Nat Commun. 2021 Sep 13;12(1):5399. (PMID: 34518535)
Cell Rep. 2018 May 29;23(9):2819-2831.e5. (PMID: 29847809)
Nucleic Acids Res. 2015 Apr 20;43(7):e47. (PMID: 25605792)
Mol Cell Proteomics. 2012 Jun;11(6):O111.016717. (PMID: 22261725)
Mol Cell Proteomics. 2021;20:100029. (PMID: 33583771)
PLoS One. 2018 Mar 29;13(3):e0195006. (PMID: 29596458)
Nat Methods. 2019 Sep;16(9):902-910. (PMID: 31384044)
Mol Syst Biol. 2018 Aug 13;14(8):e8126. (PMID: 30104418)
Mol Cell Proteomics. 2021;20:100042. (PMID: 33372048)
Nat Methods. 2020 Dec;17(12):1229-1236. (PMID: 33257825)
Anal Chem. 2016 Oct 18;88(20):10118-10125. (PMID: 27649061)
Curr Protoc Bioinformatics. 2012 Dec;Chapter 13:13.20.1-13.20.14. (PMID: 23255153)
PLoS One. 2010 Dec 07;5(12):e15004. (PMID: 21165148)
Bioinformatics. 2016 Sep 15;32(18):2847-9. (PMID: 27207943)
Glycoconj J. 2016 Jun;33(3):309-43. (PMID: 26555091)
Biochim Biophys Acta Gen Subj. 2018 Jun;1862(6):1462-1471. (PMID: 29580922)
MAbs. 2018 Oct;10(7):968-978. (PMID: 30067433)
Biochem Biophys Res Commun. 2014 Jun 13;448(4):390-6. (PMID: 24814705)
Mol Cell Proteomics. 2021;20:100010. (PMID: 33561609)
Anal Chem. 2019 Nov 5;91(21):13360-13366. (PMID: 31566965)
Nat Methods. 2020 Nov;17(11):1125-1132. (PMID: 33020657)
Nat Commun. 2021 Oct 18;12(1):6073. (PMID: 34663801)
Nat Rev Nephrol. 2019 Jun;15(6):346-366. (PMID: 30858582)
J Am Soc Mass Spectrom. 2002 Sep;13(9):1065-77. (PMID: 12322954)
PLOS Digit Health. 2022 Jan 18;1(1):e0000007. (PMID: 36812516)
Viruses. 2022 Mar 07;14(3):. (PMID: 35336960)
Sci Rep. 2016 Nov 21;6:37189. (PMID: 27869200)
Clin Chim Acta. 2012 Oct 9;413(19-20):1500-5. (PMID: 22722018)
Anal Bioanal Chem. 2019 Jul;411(19):4637-4645. (PMID: 30826852)
Nat Methods. 2020 Jan;17(1):41-44. (PMID: 31768060)
Bioinformatics. 2010 Apr 1;26(7):966-8. (PMID: 20147306)
J Am Soc Mass Spectrom. 2021 Sep 1;32(9):2366-2375. (PMID: 33871988)
Proteomics. 2015 Jul;15(13):2177-86. (PMID: 25737293)
Anal Chem. 2017 Apr 18;89(8):4532-4539. (PMID: 28353332)
Nat Commun. 2020 Oct 19;11(1):5268. (PMID: 33077710)
J Clin Endocrinol Metab. 2023 Jul 14;108(8):2087-2098. (PMID: 36658456)
Mol Cell Proteomics. 2017 Dec;16(12):2296-2309. (PMID: 29070702)
Nat Commun. 2019 Mar 21;10(1):1311. (PMID: 30899004)
Cell Syst. 2021 Aug 18;12(8):780-794.e7. (PMID: 34139154)
Curr Protein Pept Sci. 2007 Feb;8(1):91-108. (PMID: 17305563)
Mol Cell Proteomics. 2013 Dec;12(12):3444-52. (PMID: 24187339)
Nat Methods. 2021 Nov;18(11):1304-1316. (PMID: 34725484)
Biochem Soc Trans. 2021 Feb 26;49(1):161-186. (PMID: 33439247)
J Proteome Res. 2018 Feb 2;17(2):770-779. (PMID: 28901143)
Front Immunol. 2020 May 15;11:654. (PMID: 32477323)
J Am Soc Mass Spectrom. 2003 Jul;14(7):777-84. (PMID: 12837600)
Nature. 2016 Sep 14;537(7620):347-55. (PMID: 27629641)
J Proteomics. 2018 Feb 10;172:68-75. (PMID: 29069609)
Cell. 2020 Jul 9;182(1):59-72.e15. (PMID: 32492406)
J Proteome Res. 2021 Apr 2;20(4):1972-1980. (PMID: 33325715)
Mol Cell Proteomics. 2023 Feb;22(2):100486. (PMID: 36549589)
Glycoconj J. 2016 Jun;33(3):359-76. (PMID: 26638212)
Mol Cell Proteomics. 2019 Apr;18(4):686-703. (PMID: 30659065)
Science. 2021 Nov 12;374(6569):eabj1541. (PMID: 34648354)
معلومات مُعتمدة: United Kingdom WT_ Wellcome Trust; 200829/Z/16/Z United Kingdom WT_ Wellcome Trust; FC001134 United Kingdom ARC_ Arthritis Research UK; FC001134 United Kingdom WT_ Wellcome Trust
المشرفين على المادة: 0 (Glycopeptides)
0 (Ions)
تواريخ الأحداث: Date Created: 20230720 Date Completed: 20240327 Latest Revision: 20240328
رمز التحديث: 20240329
مُعرف محوري في PubMed: PMC10963274
DOI: 10.1038/s41551-023-01067-5
PMID: 37474612
قاعدة البيانات: MEDLINE
الوصف
تدمد:2157-846X
DOI:10.1038/s41551-023-01067-5